TLR4 and neoplasm: The pro-lymphatic role of TLR4 is consistent with previous reports of LPS- and HMGB1-induced inflammatory lymphangiogenesis [22,34,40], paclitaxel-induced tumor lymphangiogenesis [38], and decreased ability of TLR4-deficient mice to form lymphatic vessels compared with wild-type [35].